As in our study fasting was initiated after most participants in the MDD group had started antidepressant treatment and as the MDDlow and MDDhigh groups are characterized by their distinct respective response to therapy, a potential ketone-mediated effect of fasting on BDNF levels might be masked in the MDDlow group that responded to therapy prior to fasting. This evidence concerns the gene BDNF and major depressive disorder.